Danone Inaugurates its OneBiome Laboratory in Paris-Saclay, Strengthening its Investment in Science-Driven Gut Health innovation

Danone today announced the inauguration of its OneBiome Laboratory in Paris-Saclay, marking a major milestone in its commitment to science-based innovation and leadership in gut health research. The Danone OneBiome Lab will serve as a global hub for microbiome science, nutrition, and digital health, reinforcing Danone’s pioneering role in shaping the future of food and health. First launched in Singapore with a focus on early life, the Danone OneBiome Laboratory is designed to accelerate research into the gut microbiome and its impact on overall health, leveraging Danone’s century-long expertise, scientific data, clinical studies and a profound understanding of consumer needs. This strategic development reinforces Danone’s leadership in gut health and digital science, while bringing cutting-edge capabilities to better serve consumers and patients. It will also support the development of targeted nutrition solutions through advanced microbiology, AI, and data science. The science of the gut microbiome and the understanding of the pivotal role it plays in overall health and wellbeing has exploded over the last decades. Interest in gut health continues to rise, both within the scientific community and among consumers. Yet only one in two people believe they have a healthy microbiota1), highlighting the need for continued education and innovation in this space. “Science and innovation are at the heart of Danone’s mission to bring health through food to as many people as possible,” said Antoine de Saint-Affrique, Chief Executive Officer of Danone. “The launch of the Danone OneBiome Laboratory marks a new chapter in our Renew Strategy, deepening our capabilities in microbiome science and reinforcing our leadership in science- led health innovation.” “We believe the future of nutrition lies in understanding and harnessing the power of biotics (prebiotics, probiotics postbiotics and synbiotics) for gut health,” added Isabelle Esser, Danone’s Chief Research & Innovation Officer. “Since our founding over a century ago, Danone has been a pioneer in this field – leveraging science and technology to create biotic- enriched products that support diverse health needs across all life stages. With these new capabilities, we will continue to push the boundaries of scientific knowledge and its application in food.” The launch follows Danone’s recent acquisition of The Akkermansia Company, a trailblazer in microbiome-based gut health solutions. This strategic move strengthens Danone’s specialized nutrition and biotics’ tailored to every stage of life. In parallel, Danone’s iconic brands continue to innovate with new formulations, such as Activia Fiber, Activia Proactive, and Actimel+ Triple Action. This initiative reflects Danone’s ambition to foster collaborations, spark public interest in microbiome science, and drive thought leadership in health through food. It also reinforces our commitment to delivering science-based, targeted, and preventive nutritional solutions that meet the evolving needs of both consumers and patients.